JBCHEPHARM.NS (JBCHEPHARM.NS) Technical Analysis

As of 2026-07-21, JBCHEPHARM.NS last traded at 2,408.9 (0.00% on the day) and is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Nearest levels: 2,163.1 support below, no clear near resistance above. 14-day RSI is 67.2 (bullish).

Last updated 2026-07-21 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is JBCHEPHARM.NS in an uptrend or downtrend?

JBCHEPHARM.NS is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA.

Last close2,408.9 (0.00%)
20-day average2,375.69
50-day average2,257.3
200-day average1,975.26

Key support and resistance levels for JBCHEPHARM.NS

Derived from swing pivots over the last 200 sessions:

No clearly-defined swing levels in the current range.

LevelTypeStrengthTouches
2,163.1SupportMinor1
2,075.47SupportStrong3
1,967.1SupportModerate2

JBCHEPHARM.NS 52-week range, momentum and volatility

52-week high2,525.5 (4.6% below)
52-week low1,638.5 (47% above)
14-day RSI67.2 (Bullish)
14-day ATR46.34 (1.92% of price, Moderate volatility)

Related research pages

Frequently asked questions

Is JBCHEPHARM.NS (JBCHEPHARM.NS) in an uptrend or downtrend?

As of 2026-07-21, JBCHEPHARM.NS is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Last close 2408.9 vs 50-day average 2257.3 and 200-day average 1975.26.

What are the key support and resistance levels for JBCHEPHARM.NS?

Nearest support is around 2163.1 (minor, 1 touch). No clear resistance above price in range. Levels are derived from swing pivots over the last ~200 sessions.

What is JBCHEPHARM.NS's 52-week high and low?

Over the last 52 weeks, JBCHEPHARM.NS traded between 1638.5 and 2525.5. It is currently 4.6% below its 52-week high.

Is JBCHEPHARM.NS overbought or oversold?

The 14-day RSI is 67.2 — in a neutral 30–70 range. Momentum reads as bullish.

How volatile is JBCHEPHARM.NS?

Its 14-day Average True Range is 46.34 (1.92% of price) — moderate volatility relative to price.